Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.

Voorwinden JS, Jaspers JP, ter Beest JG, Kievit Y, Sijmons RH, Oosterwijk JC.

Clin Genet. 2012 May;81(5):421-9. doi: 10.1111/j.1399-0004.2011.01811.x. Epub 2011 Dec 13.

PMID:
22091929
2.

Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A.

Clin Genet. 2007 Jan;71(1):35-42.

PMID:
17204044
3.

Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.

Baumanis L, Evans JP, Callanan N, Susswein LR.

J Genet Couns. 2009 Oct;18(5):447-63. doi: 10.1007/s10897-009-9238-8. Epub 2009 May 22.

PMID:
19462222
4.

Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.

Vos J, Menko FH, Oosterwijk JC, van Asperen CJ, Stiggelbout AM, Tibben A.

Psychooncology. 2013 May;22(5):1167-76. doi: 10.1002/pon.3125. Epub 2012 Jul 9.

PMID:
22777929
5.

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N.

Fam Cancer. 2014 Jun;13(2):143-51. doi: 10.1007/s10689-013-9686-z.

PMID:
24068317
6.

Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A.

Patient Educ Couns. 2007 Jan;65(1):58-68. Epub 2006 Jul 26.

PMID:
16872788
7.

Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.

Metcalfe KA, Poll A, Llacuachaqui M, Nanda S, Tulman A, Mian N, Sun P, Narod SA.

Clin Genet. 2010 Nov;78(5):411-7. doi: 10.1111/j.1399-0004.2010.01499.x. Epub 2010 Jul 28.

PMID:
20653694
8.
9.

Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome.

Bruwer Z, Futter M, Ramesar R.

Patient Educ Couns. 2013 Jul;92(1):53-60. doi: 10.1016/j.pec.2013.02.001. Epub 2013 Feb 28.

PMID:
23453851
10.

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A.

Eur J Cancer. 2007 Jan;43(1):71-7. Epub 2006 Oct 11.

PMID:
17045473
11.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

12.

Intention to learn results of genetic testing for hereditary colon cancer.

Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):353-60.

13.

Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.

Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, Jansen AM, Stiggelbout AM, Tibben A.

Patient Educ Couns. 2012 Feb;86(2):239-51. doi: 10.1016/j.pec.2011.04.017. Epub 2011 Dec 27.

PMID:
21684708
14.

Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.

Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P, Rantanen E, Kääriäinen H, Mecklin JP.

J Med Genet. 2007 Nov;44(11):732-8. Epub 2007 Jul 14.

15.

No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.

Dorval M, Gauthier G, Maunsell E, Dugas MJ, Rouleau I, Chiquette J, Plante M, Laframboise R, Gaudet M, Bridge PJ, Simard J.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2862-7.

16.

A comparison of counselee and counselor satisfaction in reproductive genetic counseling.

Aalfs CM, Oort FJ, de Haes JC, Leschot NJ, Smets EM.

Clin Genet. 2007 Aug;72(2):74-82.

PMID:
17661810
17.

An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.

Segal J, Esplen MJ, Toner B, Baedorf S, Narod S, Butler K.

Am J Med Genet A. 2004 Mar 15;125A(3):267-72.

PMID:
14994235
18.

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W.

J Clin Oncol. 2006 Aug 1;24(22):3672-7.

PMID:
16877736
19.

Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.

Landsbergen KM, Prins JB, Brunner HG, Hoogerbrugge N.

Genet Couns. 2009;20(4):317-25.

PMID:
20162866
20.

Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Aktan-Collan K, Mecklin JP, de la Chapelle A, Peltomäki P, Uutela A, Kääriäinen H.

J Med Genet. 2000 Feb;37(2):108-13.

Supplemental Content

Support Center